Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.

Valero-Jiménez A, Zúñiga J, Cisneros J, Becerril C, Salgado A, Checa M, Buendía-Roldán I, Mendoza-Milla C, Gaxiola M, Pardo A, Selman M.

PLoS One. 2018 Mar 12;13(3):e0192963. doi: 10.1371/journal.pone.0192963. eCollection 2018.

2.

Publisher Correction: Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway.

Benedetti E, Pučić-Baković M, Keser T, Wahl A, Hassinen A, Yang JY, Liu L, Trbojević-Akmačić I, Razdorov G, Štambuk J, Klarić L, Ugrina I, Selman MHJ, Wuhrer M, Rudan I, Polasek O, Hayward C, Grallert H, Strauch K, Peters A, Meitinger T, Gieger C, Vilaj M, Boons GJ, Moremen KW, Ovchinnikova T, Bovin N, Kellokumpu S, Theis FJ, Lauc G, Krumsiek J.

Nat Commun. 2018 Feb 13;9(1):706. doi: 10.1038/s41467-017-02379-2.

3.

Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis.

Afratis NA, Selman M, Pardo A, Sagi I.

Matrix Biol. 2018 Feb 9. pii: S0945-053X(17)30436-5. doi: 10.1016/j.matbio.2018.02.007. [Epub ahead of print] Review.

PMID:
29428229
4.

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA.

Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9.

5.

Upregulation and Nuclear Location of MMP28 in Alveolar Epithelium of Idiopathic Pulmonary Fibrosis.

Maldonado M, Salgado-Aguayo A, Herrera I, Cabrera S, Ortíz-Quintero B, Staab-Weijnitz CA, Eickelberg O, Ramírez R, Manicone AM, Selman M, Pardo A.

Am J Respir Cell Mol Biol. 2018 Jan 26. doi: 10.1165/rcmb.2017-0223OC. [Epub ahead of print]

PMID:
29373068
6.

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition.

Selman M, Ou P, Rousso C, Bergeron A, Krishnan R, Pikor L, Chen A, Keller BA, Ilkow C, Bell JC, Diallo JS.

Sci Transl Med. 2018 Jan 24;10(425). pii: eaao1613. doi: 10.1126/scitranslmed.aao1613.

PMID:
29367345
7.

R-spondin 2 is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblasts Behavior.

Munguía-Reyes A, Balderas-Martínez YI, Becerril C, Checa M, Ramírez R, Ortíz-Quintero B, Meléndez-Zajgla J, Pardo A, Selman M.

Am J Respir Cell Mol Biol. 2018 Jan 18. doi: 10.1165/rcmb.2017-0115OC. [Epub ahead of print]

PMID:
29345973
8.

The rise of interstitial lung diseases?

Pérez-Padilla R, Selman M.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):5-6. doi: 10.5588/ijtld.17.0751. No abstract available.

PMID:
29297420
9.

Corrigendum: ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec 7;23(12):1499. doi: 10.1038/nm1217-1499b.

PMID:
29216045
10.

Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Selman M, Rousso C, Bergeron A, Son HH, Krishnan R, El-Sayes NA, Varette O, Chen A, Le Boeuf F, Tzelepis F, Bell JC, Crans DC, Diallo JS.

Mol Ther. 2018 Jan 3;26(1):56-69. doi: 10.1016/j.ymthe.2017.10.014. Epub 2017 Oct 24.

PMID:
29175158
11.

Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway.

Benedetti E, Pučić-Baković M, Keser T, Wahl A, Hassinen A, Yang JY, Liu L, Trbojević-Akmačić I, Razdorov G, Štambuk J, Klarić L, Ugrina I, Selman MHJ, Wuhrer M, Rudan I, Polasek O, Hayward C, Grallert H, Strauch K, Peters A, Meitinger T, Gieger C, Vilaj M, Boons GJ, Moremen KW, Ovchinnikova T, Bovin N, Kellokumpu S, Theis FJ, Lauc G, Krumsiek J.

Nat Commun. 2017 Nov 14;8(1):1483. doi: 10.1038/s41467-017-01525-0. Erratum in: Nat Commun. 2018 Feb 13;9(1):706.

12.

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Mora AL, Rojas M, Pardo A, Selman M.

Nat Rev Drug Discov. 2017 Oct 30;16(11):810. doi: 10.1038/nrd.2017.225. No abstract available.

13.

ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.

Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, Santos DM, Grasberger P, Ahluwalia N, Montesi SB, Shea BS, Black KE, Knipe R, Blati M, Baron M, Wu B, Fahmi H, Gandhi R, Pardo A, Selman M, Wu J, Pelletier JP, Martel-Pelletier J, Tager AM, Kapoor M.

Nat Med. 2017 Dec;23(12):1405-1415. doi: 10.1038/nm.4419. Epub 2017 Oct 23. Erratum in: Nat Med. 2017 Dec 7;23 (12 ):1499.

14.

Idiopathic pulmonary fibrosis.

Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU.

Nat Rev Dis Primers. 2017 Oct 20;3:17074. doi: 10.1038/nrdp.2017.74. Review.

PMID:
29052582
15.

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension.

Richeldi L, Kreuter M, Selman M, Crestani B, Kirsten AM, Wuyts WA, Xu Z, Bernois K, Stowasser S, Quaresma M, Costabel U.

Thorax. 2018 Jun;73(6):581-583. doi: 10.1136/thoraxjnl-2016-209701. Epub 2017 Oct 9.

16.

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Mora AL, Rojas M, Pardo A, Selman M.

Nat Rev Drug Discov. 2017 Nov;16(11):755-772. doi: 10.1038/nrd.2017.170. Epub 2017 Oct 6. Review. Erratum in: Nat Rev Drug Discov. 2017 Oct 30;16(11):810.

PMID:
28983101
17.

Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health.

Plomp R, Ruhaak LR, Uh HW, Reiding KR, Selman M, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Wuhrer M.

Sci Rep. 2017 Sep 26;7(1):12325. doi: 10.1038/s41598-017-12495-0.

18.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

19.

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.

Joshi S, Singh AR, Wong SS, Zulcic M, Jiang M, Pardo A, Selman M, Hagood JS, Durden DL.

PLoS One. 2017 Aug 17;12(8):e0182851. doi: 10.1371/journal.pone.0182851. eCollection 2017.

20.

Small airway dysfunction in chronic hypersensitivity pneumonitis.

Guerrero Zúñiga S, Sánchez Hernández J, Mateos Toledo H, Mejía Ávila M, Gochicoa-Rangel L, Miguel Reyes JL, Selman M, Torre-Bouscoulet L.

Respirology. 2017 Nov;22(8):1637-1642. doi: 10.1111/resp.13124. Epub 2017 Jul 26.

PMID:
28748646
21.

Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.

Buendía-Roldán I, Mejía M, Navarro C, Selman M.

Respir Med. 2017 Aug;129:46-52. doi: 10.1016/j.rmed.2017.06.001. Epub 2017 Jun 3. Review.

PMID:
28732835
22.

Improving biocuration of microRNAs in diseases: a case study in idiopathic pulmonary fibrosis.

Balderas-Martínez YI, Rinaldi F, Contreras G, Solano-Lira H, Sánchez-Pérez M, Collado-Vides J, Selman M, Pardo A.

Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax030.

23.

Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.

Le Boeuf F, Selman M, Son HH, Bergeron A, Chen A, Tsang J, Butterwick D, Arulanandam R, Forbes NE, Tzelepis F, Bell JC, Werier J, Abdelbary H, Diallo JS.

Int J Cancer. 2017 Sep 15;141(6):1257-1264. doi: 10.1002/ijc.30813. Epub 2017 Jun 21.

PMID:
28568891
24.

The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.

Budinger GRS, Kohanski RA, Gan W, Kobor MS, Amaral LA, Armanios M, Kelsey KT, Pardo A, Tuder R, Macian F, Chandel N, Vaughan D, Rojas M, Mora AL, Kovacs E, Duncan SR, Finkel T, Choi A, Eickelberg O, Chen D, Agusti A, Selman M, Balch WE, Busse P, Lin A, Morimoto R, Sznajder JI, Thannickal VJ.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1492-1500. doi: 10.1093/gerona/glx090. Review.

25.

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.

Jenkins RG, Moore BB, Chambers RC, Eickelberg O, Königshoff M, Kolb M, Laurent GJ, Nanthakumar CB, Olman MA, Pardo A, Selman M, Sheppard D, Sime PJ, Tager AM, Tatler AL, Thannickal VJ, White ES; ATS Assembly on Respiratory Cell and Molecular Biology.

Am J Respir Cell Mol Biol. 2017 May;56(5):667-679. doi: 10.1165/rcmb.2017-0096ST.

26.

SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis.

Jablonski RP, Kim SJ, Cheresh P, Williams DB, Morales-Nebreda L, Cheng Y, Yeldandi A, Bhorade S, Pardo A, Selman M, Ridge K, Gius D, Budinger GRS, Kamp DW.

FASEB J. 2017 Jun;31(6):2520-2532. doi: 10.1096/fj.201601077R. Epub 2017 Mar 3.

PMID:
28258190
27.

Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection.

Treerat P, Prince O, Cruz-Lagunas A, Muñoz-Torrico M, Salazar-Lezama MA, Selman M, Fallert-Junecko B, Reinhardt TA, Alcorn JF, Kaushal D, Zuñiga J, Rangel-Moreno J, Kolls JK, Khader SA.

Mucosal Immunol. 2017 Jul;10(4):1069-1081. doi: 10.1038/mi.2017.15. Epub 2017 Mar 1.

28.

Fibroblast Senescence and Apoptosis. "One-Two Punch" to Slow Down Lung Fibrosis?

Pardo A, Selman M.

Am J Respir Cell Mol Biol. 2017 Feb;56(2):145-146. doi: 10.1165/rcmb.2016-0387ED. No abstract available.

PMID:
28145776
29.

Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.

Pardo A, Selman M.

Ann Am Thorac Soc. 2016 Dec;13(Supplement_5):S417-S421. doi: 10.1513/AnnalsATS.201605-341AW. Review.

PMID:
28005427
30.

Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.

Buendía-Roldán I, Ruiz V, Sierra P, Montes E, Ramírez R, Vega A, Salgado A, Vargas MH, Mejía M, Pardo A, Selman M.

PLoS One. 2016 Dec 15;11(12):e0168552. doi: 10.1371/journal.pone.0168552. eCollection 2016.

31.

mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts.

Romero Y, Bueno M, Ramirez R, Álvarez D, Sembrat JC, Goncharova EA, Rojas M, Selman M, Mora AL, Pardo A.

Aging Cell. 2016 Aug 26. doi: 10.1111/acel.12514. [Epub ahead of print]

32.

Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.

Shimbori C, Bellaye PS, Xia J, Gauldie J, Ask K, Ramos C, Becerril C, Pardo A, Selman M, Kolb M.

J Pathol. 2016 Oct;240(2):197-210. doi: 10.1002/path.4768.

PMID:
27425145
33.

Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis.

Selman M, López-Otín C, Pardo A.

Eur Respir J. 2016 Aug;48(2):538-52. doi: 10.1183/13993003.00398-2016. Epub 2016 Jul 7. Review.

34.

IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.

de Jong SE, Selman MH, Adegnika AA, Amoah AS, van Riet E, Kruize YC, Raynes JG, Rodriguez A, Boakye D, von Mutius E, Knulst AC, Genuneit J, Cooper PJ, Hokke CH, Wuhrer M, Yazdanbakhsh M.

Sci Rep. 2016 Jun 16;6:28207. doi: 10.1038/srep28207.

35.

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.

Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA.

BMC Genet. 2016 Jun 7;17(1):74. doi: 10.1186/s12863-016-0377-2.

36.

First-in-class small molecule potentiators of cancer virotherapy.

Dornan MH, Krishnan R, Macklin AM, Selman M, El Sayes N, Son HH, Davis C, Chen A, Keillor K, Le PJ, Moi C, Ou P, Pardin C, Canez CR, Le Boeuf F, Bell JC, Smith JC, Diallo JS, Boddy CN.

Sci Rep. 2016 May 26;6:26786. doi: 10.1038/srep26786.

37.

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.

Bourgeois-Daigneault MC, Roy DG, Falls T, Twumasi-Boateng K, St-Germain LE, Marguerie M, Garcia V, Selman M, Jennings VA, Pettigrew J, Amos S, Diallo JS, Nelson B, Bell JC.

Mol Ther Oncolytics. 2016 Feb 17;3:16001. doi: 10.1038/mto.2016.1. eCollection 2016.

38.

Aging and Pulmonary Fibrosis.

Selman M, Buendía-Roldán I, Pardo A.

Rev Invest Clin. 2016 Mar-Apr;68(2):75-83. Review.

39.

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis.

Pardo A, Cabrera S, Maldonado M, Selman M.

Respir Res. 2016 Mar 4;17:23. doi: 10.1186/s12931-016-0343-6. Review.

40.

Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells.

Checa M, Hagood JS, Velazquez-Cruz R, Ruiz V, García-De-Alba C, Rangel-Escareño C, Urrea F, Becerril C, Montaño M, García-Trejo S, Cisneros Lira J, Aquino-Gálvez A, Pardo A, Selman M.

PLoS One. 2016 Mar 2;11(3):e0150383. doi: 10.1371/journal.pone.0150383. eCollection 2016.

41.

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.

Richeldi L, Cottin V, du Bois RM, Selman M, Kimura T, Bailes Z, Schlenker-Herceg R, Stowasser S, Brown KK.

Respir Med. 2016 Apr;113:74-9. doi: 10.1016/j.rmed.2016.02.001. Epub 2016 Feb 3.

42.

Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.

Park AM, Kanai K, Itoh T, Sato T, Tsukui T, Inagaki Y, Selman M, Matsushima K, Yoshie O.

PLoS One. 2016 Feb 9;11(2):e0148998. doi: 10.1371/journal.pone.0148998. eCollection 2016.

43.

The genome of an Encephalitozoon cuniculi type III strain reveals insights into the genetic diversity and mode of reproduction of a ubiquitous vertebrate pathogen.

Pelin A, Moteshareie H, Sak B, Selman M, Naor A, Eyahpaise MÈ, Farinelli L, Golshani A, Kvac M, Corradi N.

Heredity (Edinb). 2016 May;116(5):458-65. doi: 10.1038/hdy.2016.4. Epub 2016 Feb 3.

44.

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.

Wuhrer M, Selman MH, McDonnell LA, Kümpfel T, Derfuss T, Khademi M, Olsson T, Hohlfeld R, Meinl E, Krumbholz M.

J Neuroinflammation. 2015 Dec 18;12:235. doi: 10.1186/s12974-015-0450-1.

45.

Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Ahluwalia N, Grasberger PE, Mugo BM, Feghali-Bostwick C, Pardo A, Selman M, Lagares D, Tager AM.

Am J Respir Cell Mol Biol. 2016 Jun;54(6):831-42. doi: 10.1165/rcmb.2015-0040OC.

46.

Analysis of heat shock protein 70 gene polymorphisms Mexican patients with idiopathic pulmonary fibrosis.

Aquino-Gálvez A, González-Ávila G, Pérez-Rodríguez M, Partida-Rodríguez O, Nieves-Ramírez M, Piña-Ramírez I, Ramírez-Martínez G, Castillejos-López M, Checa M, Ruiz V, Urrea F, Sommer B, Zúñiga J, Selman M.

BMC Pulm Med. 2015 Oct 24;15:129. doi: 10.1186/s12890-015-0127-7.

47.

Chronology of estrogen receptor expression in testes of mouse embryos.

Mahmoud IJ, Selman MO, Shebeb WR.

Turk J Med Sci. 2015;45(3):526-33.

PMID:
26281315
48.

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ; American Thoracic Society; European Respiratory society; Japanese Respiratory Society; Latin American Thoracic Association.

Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19. doi: 10.1164/rccm.201506-1063ST. Erratum in: Am J Respir Crit Care Med. 2015 Sep 1;192(5):644. Dosage error in article text.

PMID:
26177183
49.

Increased alveolar soluble annexin V promotes lung inflammation and fibrosis.

Buckley S, Shi W, Xu W, Frey MR, Moats R, Pardo A, Selman M, Warburton D.

Eur Respir J. 2015 Nov;46(5):1417-29. doi: 10.1183/09031936.00002115. Epub 2015 Jul 9.

50.

Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.

Kim SY, Diggans J, Pankratz D, Huang J, Pagan M, Sindy N, Tom E, Anderson J, Choi Y, Lynch DA, Steele MP, Flaherty KR, Brown KK, Farah H, Bukstein MJ, Pardo A, Selman M, Wolters PJ, Nathan SD, Colby TV, Myers JL, Katzenstein AL, Raghu G, Kennedy GC.

Lancet Respir Med. 2015 Jun;3(6):473-82. doi: 10.1016/S2213-2600(15)00140-X. Epub 2015 May 20.

PMID:
26003389

Supplemental Content

Loading ...
Support Center